Developer Tools Late Stage Investors & VC Firms
40 firms in this list, with a median first check of $500K. 16 of them lead rounds. Generated from verified public data and updated continuously.
Insight Partners
New YorkSeed–Late Stage$120M – $350M
318 people
Bessemer Venture Partners
Redwood CitySeed–Late Stage$5M – $100M
58 people
Index Ventures
San FranciscoSeed–Late Stage$540K – $10.8M
86 people
Khosla Ventures
Menlo ParkPre-Seed–Late Stage$5K – $50M
56 people
DCVC (Data Collective)
Palo AltoPre-Seed–Late Stage$5M – $25M
66 people
GV (Google Ventures)
Mountain ViewSeed–Late Stage$250K – $50M
72 people
Sequoia Capital
Menlo ParkPre-Seed–Late Stage$4.4M – $214M
44 people
Accel
Palo AltoSeed–Late Stage$1.6M – $70M
64 people
Kleiner Perkins
Menlo ParkPre-Seed–Late Stage$500K – $15M
48 people
Paladin Capital Group
WashingtonSeed–Late Stage$100K – $5M
73 people
Blumberg Capital
MiamiPre-Seed–Late Stage$500K – $5M
32 people
Craft Ventures
San FranciscoPre-Seed–Late Stage$50K – $50M
45 people
Inovia Capital
MontrealPre-Seed–Late Stage$250K – $8M
59 people
Alumni Ventures
ManchesterPre-Seed–Late Stage$100K – $10M
28 people
Basecamp Fund
ManchesterPre-Seed–Late Stage$100K – $10M
19 people
Venrock
Palo AltoSeed–Late Stage$500K – $10M
54 people
Olive Tree Capital
BostonSeed–Late Stage
5 people
Pitango
Tel AvivPre-Seed–Late Stage$4M – $100M
48 people
BIP Ventures
AtlantaPre-Seed–Late Stage
19 people
FirstMark
New YorkPre-Seed–Late Stage$250K – $10M
40 people
Geodesic Capital
Foster CitySeed–Late Stage
12 people
Visionaries Club
BerlinPre-Seed–Late Stage$900K
16 people
VenturEast
BangaloreSeed–Late Stage
12 people
Cervin
Palo AltoPre-Seed–Late Stage
10 people
Related lists
Late Stage Investors & VC Firms (2864)Late Stage Investors & VC Firms in United States (1049)Healthtech Late Stage Investors & VC Firms (847)Late Stage Investors & VC Firms in Global (801)Enterprise Software Late Stage Investors & VC Firms (801)SaaS Late Stage Investors & VC Firms (784)Fintech Late Stage Investors & VC Firms (656)Consumer Late Stage Investors & VC Firms (627)Biotech Late Stage Investors & VC Firms (625)Late Stage Investors & VC Firms in Europe (617)
Data sourced from public filings and firms' own websites — see our methodology.















































































